Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective EMR Study to Assess Changes in Immunoglobulins in Patients With Relapsing Forms of Multiple Sclerosis Treated With Anti-CD20 Monoclonal Antibodies

NCT06526000 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT06526000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06526000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective EMR Study to Assess Changes in Immunoglobulins in Patients With Relapsing Forms of Multiple Sclerosis Treated With Anti-CD20 Monoclonal Antibodies
Lead sponsor
Novartis
Phase
Observational
Overall status
Completed
Start date
October 11, 2022
Completion date
February 28, 2024
Enrollment
326 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome, relapsing multiple sclerosis, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis